Posted in | Life Sciences

Redefining pharma - the incredible potential of mass spectrometry

Mike GreigExecutive DirectorBruker Scientific

Join Kate Stumpo for this new episode of omg OMx as she discusses the future of mass spectrometry in pharma with Bruker's Mike Greig.

Watch the full episode below:

Mike Greig | omg OMx Podcast | Ep. 9

About the speaker

Mike Greig is the Executive Director and Global Pharma/BioPharma Market at Bruker Scientific, LLC.

omg OMx host: Kate Stumpo, Senior Market Manager at Bruker

 LinkedIn

Other Podcasts by this Supplier

Life Science Podcasts by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.